Among cancers, previous studies have reported that low surface expression of CD80 was associated with the immune escape mechanism of colon cancer, and upregulating CD80 on tumor cell surface successfully enhances antitumor immune responses (Bhatia et al., 2006). Here, CD80 is linked to cancer.